SOUTH SAN FRANCISCO, Calif., Dec. 20 /PRNewswire-FirstCall/ -- Genentech, Inc. will announce its 2006 4th quarter and year-end earnings on Wednesday, January 10, 2007, after the markets close.
The announcement will be followed by a live webcast at 2:15 p.m. Pacific Time of a discussion by Genentech management of earnings and other business results. The webcast can be accessed on Genentech's web site at http://www.gene.com/ and will be archived and available for replay until 5:00 p.m. Pacific Time on January 24, 2007.
A telephonic replay of the webcast will be available beginning at 5:15 p.m. Pacific Time on January 10, 2007 through 5:15 p.m. Pacific Time on January 17, 2007. Access numbers for this replay are: 1-888-203-1112 (U.S./Canada) and 1-719-457-0820 (international); Conference ID number is 6237984.
About Genentech
Founded 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for significant unmet medical needs. A considerable number of the currently approved biotechnology products originated from or are based on Genentech science. Genentech manufactures and commercializes multiple biotechnology products and licenses several additional products to other companies. The company has headquarters in South San Francisco, California and is listed on the New York Stock Exchange under the symbol DNA. For additional information about the company, please visit http://www.gene.com/ .
CONTACT: media, Caroline Pecquet, +1-650-467-7078, or investors, Diane Schrick, +1-650-225-1599.
